Topamax (topiramate) is now approved to PREVENT migraines

October 2004

Topamax (topiramate) is now approved to PREVENT migraines.

Nearly half of patients have 50% fewer migraines while on Topamax. This is comparable to current preventive drugs such as tricyclics...divalproex...and beta-blockers.

Patients start on 25 mg/day, then slowly increase up to 50 to 100 mg BID. This is lower than the dose used for seizures.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

"better" cholesterol tests
Antiplatelets patients take BOTH aspirin and Plavix (clopidogrel)
increasing pressure for drug companies to register ALL their studies
Gastroenterology Zelnorm (tegaserod) is now approved for idiopathic chronic constipation
Neurology & Pain Cymbalta will be used for neuropathic pain
Neurology & Pain whether Neurontin is linked to suicides
Women's Health polycystic ovary syndrome (PCOS)
Migraine Topamax (topiramate) is now approved to PREVENT migraines
Supplements American ginseng and St. John's wort might DECREASE warfarin's anticoagulant effects
Supplements "cortisol blockers" for weight loss
Thyroid Disorders switch levothyroxine products
ADHD treating ADHD in ADULTS

Topamax (topiramate) is now approved to PREVENT migraines

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents